DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $ACHR--Archer Aviation Inc. (NYSE: ACHR) today announced an agreement to supply Anduril Industries and EDGE Group with Archer's dual use electric powertrain technology to accelerate the development and scaled production of Anduril's recently unveiled Omen Autonomous Air Vehicle system. The UAE has committed to an initial acquisition of 50 Omen systems, creating an established demand signal for the Omen system and Archer's powertrain technology. The agreeme.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BLUE OWL CAPITAL INC. (OWL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 16, 2025, the Financial Times published an article d.

Flexible Solutions International, Inc. ( FSI ) Q3 2025 Earnings Call November 17, 2025 11:00 AM EST Company Participants Daniel O'Brien - President, CEO, Principal Financial & Accounting Officer and Director Conference Call Participants Timothy Clarkson - Van Clemens & Co. Incorporated David Marsh - Singular Research, LLC Gregg Hillman William Gregozeski - Greenridge Global LLC Manny Stoupakis - Geoinvesting, LLC Raymond Howe Presentation Operator Good day, everyone, and welcome to today's Flexible Solutions International's Third Quarter 2025 Financials Conference Call. [Operator Instructions] Please note, this call is being recorded, and I will be standing by if you should need …

JinkoSolar Holding Co., Ltd. ( JKS ) Q3 2025 Earnings Call November 17, 2025 7:30 AM EST Company Participants Stella Wang - Investor Relations Officer Xiande Li - Co-Founder, CEO & Chairman of the Board Gener Miao Mengmeng Li - Chief Financial Officer Haiyun Cao - CFO & Deputy GM Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Alan Lau - Jefferies LLC, Research Division Rajiv Chaudhri Tyler Bisset - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen, and thank you for standing by for JinkoSolar Holding Co., Ltd.

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport-McMoran Inc. (NYSE: FCX) securities between February 15, 2022 and September 24, 2025. Freeport is a mining company.

Forget about reshoring manufacturing without more skilled workers.

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the "Class Period"). The Class Period was expanded to include more investors.

Market Domination Overtime anchor Josh Lipton breaks down the day's market action for November 17, 2025. Dow Jones Industrial Average sold off more than 500 points, while the S&P 500 and Nasdaq also slipped.

Covered call ETFs have soared in attention recently due to the combination of attractive yield and blue-chip tech stock exposure they provide. However, I think most of these funds are structurally flawed. There is one fund that mitigates most of these issues, making it potentially worthy of investment: the Goldman Sachs Nasdaq-100 Premium Income ETF.

ROCKVILLE, Md. , Nov. 17, 2025 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA) today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock.

TGTX has seen rapid enrolment of the ENHANCE study which could allow a simplified dosing regime of IV Briumvi. A readout is possible for mid-2026. Investors may need to wait longer for the subcutaneous formulation of Briumvi to become available, with a readout from clinical work possible in late 2026 or early 2027. Kyverna Therapeutics's KYV-101 is emerging as a potential competitor to TGTX's Azer-cel in Multiple Sclerosis, although initial KYV-101 data is from a handful of patients.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2025 fourth quarter results after the market close on Monday, November 24, 2025. Management will host a conference call on Tuesday, November 25, 2025 at 9:00 a.m.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important December 2, 2025 lead plaintiff deadline.

PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one meetings with investors at the Jefferies Global Healthcare Conference, being held on November 17-20, 2025 in London, United Kingdom.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RCI Hospitality Holdings, Inc. (NASDAQ: RICK) between December 15, 2021 and September 16, 2025, both dates inclusive (the “Class Period”), of the important November 20, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased RCI Hospitality securities during the Class Period you may be entitled to compensation without payme.

Alkermes plc ( ALKS ) Shareholder/Analyst Call November 12, 2025 8:30 AM EST Company Participants Sandra Coombs - Senior Vice President of Corporate Affairs & Investor Relations Richard F. Pops - Chairman & CEO Craig Hopkinson - Executive VP of Research & Development and Chief Medical Officer Conference Call Participants Joon Lee - Truist Securities, Inc., Research Division Julian Pino - Stifel, Nicolaus & Company, Incorporated, Research Division Luke Herrmann - Robert W.

McGraw Hill, Inc. ( MH ) Q2 2026 Earnings Call November 12, 2025 8:30 AM EST Company Participants Danielle Kloeblen - Senior Vice President of Finance & Investor Relations Simon Allen - CEO, President & Chairman Robert Sallmann - Executive VP & CFO Conference Call Participants Ryan MacDonald - Needham & Company, LLC, Research Division Henry Hayden - Rothschild & Co Redburn, Research Division Stephen Sheldon - William Blair & Company L.L.C., Research Division Steven Koenig - Macquarie Research Keen Fai Tong - Goldman Sachs Group, Inc., Research Division Marvin Fong - BTIG, LLC, Research Division Toni Kaplan - Morgan …

Many investors have taken a glass-half-full view of markets lately. But others see the glass as cracked.

Amplitude offers a compelling value opportunity with bargain-basement multiples and a turnaround in fundamentals not yet fully appreciated by the market. AMPL's Q3 beat-and-raise quarter, accelerating revenue growth, and rising RPO signal a positive long-term trajectory and improving customer commitments. At just over $10 per share, AMPL trades at low revenue multiples, with potential for significant upside if assigned even conservative industry valuations.

MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.